Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159).

Marvaso G, Ciardo D, Corrao G, Gandini S, Fodor C, Zerini D, Rojas DP, Augugliaro M, Bonizzi G, Pece S, Cattani F, Mazzocco K, Mistretta FA, Musi G, Alessi S, Petralia G, Pravettoni G, De Cobelli O, Di Fiore PP, Viale G, Orecchia R, Jereczek-Fossa BA.

BMC Cancer. 2019 Sep 10;19(1):903. doi: 10.1186/s12885-019-6117-z.

2.

Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer.

Noberini R, Restellini C, Savoia EO, Raimondi F, Ghiani L, Jodice MG, Bertalot G, Bonizzi G, Capra M, Maffini FA, Tagliabue M, Ansarin M, Lupia M, Giordano M, Osti D, Pelicci G, Chiocca S, Bonaldi T.

Cancers (Basel). 2019 May 24;11(5). pii: E723. doi: 10.3390/cancers11050723.

3.

Subclinical endometritis in beef cattle in early and late postpartum: Cytology, bacteriology, haptoglobin and test strip efficiency to evaluate the evolution of the disease.

Ricci A, Bonizzi G, Sarasso G, Gallo S, Dondo A, Zoppi S, Vincenti L.

Theriogenology. 2017 May;94:86-93. doi: 10.1016/j.theriogenology.2017.02.006. Epub 2017 Feb 20.

PMID:
28407866
4.

Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients.

Pruneri G, Bonizzi G, Vingiani A.

Curr Opin Oncol. 2016 Nov;28(6):476-483. Review.

PMID:
27649027
5.

Optimization and Standardization of Circulating MicroRNA Detection for Clinical Application: The miR-Test Case.

Marzi MJ, Montani F, Carletti RM, Dezi F, Dama E, Bonizzi G, Sandri MT, Rampinelli C, Bellomi M, Maisonneuve P, Spaggiari L, Veronesi G, Bianchi F, Di Fiore PP, Nicassio F.

Clin Chem. 2016 May;62(5):743-54. doi: 10.1373/clinchem.2015.251942.

6.

A Trust-Based Pact in Research Biobanks. From Theory to Practice.

Sanchini V, Bonizzi G, Disalvatore D, Monturano M, Pece S, Viale G, Di Fiore PP, Boniolo G.

Bioethics. 2016 May;30(4):260-71. doi: 10.1111/bioe.12184. Epub 2015 Aug 26.

PMID:
26307361
7.

miR-Test: a blood test for lung cancer early detection.

Montani F, Marzi MJ, Dezi F, Dama E, Carletti RM, Bonizzi G, Bertolotti R, Bellomi M, Rampinelli C, Maisonneuve P, Spaggiari L, Veronesi G, Nicassio F, Di Fiore PP, Bianchi F.

J Natl Cancer Inst. 2015 Mar 19;107(6):djv063. doi: 10.1093/jnci/djv063. Print 2015 Jun.

PMID:
25794889
8.

The emerging role of p53 in stem cells.

Bonizzi G, Cicalese A, Insinga A, Pelicci PG.

Trends Mol Med. 2012 Jan;18(1):6-12. doi: 10.1016/j.molmed.2011.08.002. Epub 2011 Sep 7.

9.

Setting sights on the right target: p53 and stem cell division.

Pasi CE, Bonizzi G, Pelicci P.

Cell Cycle. 2010 Jun 15;9(12):2265-6. Epub 2010 Jun 15. No abstract available.

PMID:
20519955
10.

The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, Pelicci PG.

Cell. 2009 Sep 18;138(6):1083-95. doi: 10.1016/j.cell.2009.06.048.

11.

Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals.

Mills DM, Bonizzi G, Karin M, Rickert RC.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6359-64. Epub 2007 Apr 2.

12.

Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.

Enzler T, Bonizzi G, Silverman GJ, Otero DC, Widhopf GF, Anzelon-Mills A, Rickert RC, Karin M.

Immunity. 2006 Sep;25(3):403-15.

13.

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

Munzone E, Curigliano G, Rocca A, Bonizzi G, Renne G, Goldhirsch A, Nolè F.

Breast Cancer Res. 2006;8(1):R4. Epub 2005 Dec 7. Erratum in: Breast Cancer Res. 2006;8(5):407.

14.

Breast cancer vaccines: a clinical reality or fairy tale?

Curigliano G, Spitaleri G, Pietri E, Rescigno M, de Braud F, Cardillo A, Munzone E, Rocca A, Bonizzi G, Brichard V, Orlando L, Goldhirsch A.

Ann Oncol. 2006 May;17(5):750-62. Epub 2005 Nov 17. Review.

PMID:
16293674
15.
16.

Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.

Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M.

EMBO J. 2004 Oct 27;23(21):4202-10. Epub 2004 Oct 7.

17.

The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

Bonizzi G, Karin M.

Trends Immunol. 2004 Jun;25(6):280-8. Review. No abstract available.

PMID:
15145317
18.

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, Karin M.

Cell. 2001 Dec 14;107(6):763-75.

19.

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Senftleben U, Cao Y, Xiao G, Greten FR, Krähn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M.

Science. 2001 Aug 24;293(5534):1495-9.

20.

NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment.

Bours V, Bonizzi G, Bentires-Alj M, Bureau F, Piette J, Lekeux P, Merville M.

Toxicology. 2000 Nov 16;153(1-3):27-38. Review.

PMID:
11090945
21.

Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma.

Bureau F, Delhalle S, Bonizzi G, Fiévez L, Dogné S, Kirschvink N, Vanderplasschen A, Merville MP, Bours V, Lekeux P.

J Immunol. 2000 Nov 15;165(10):5822-30.

22.

Non-enzymatic triggering of the ceramide signalling cascade by solar UVA radiation.

Grether-Beck S, Bonizzi G, Schmitt-Brenden H, Felsner I, Timmer A, Sies H, Johnson JP, Piette J, Krutmann J.

EMBO J. 2000 Nov 1;19(21):5793-800.

23.

Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma.

Bureau F, Bonizzi G, Kirschvink N, Delhalle S, Desmecht D, Merville MP, Bours V, Lekeux P.

Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1314-21.

PMID:
10764329
24.

Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.

Bonizzi G, Piette J, Merville MP, Bours V.

Biochem Pharmacol. 2000 Jan 1;59(1):7-11. Review.

PMID:
10605929
25.
26.

Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.

Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP, Bours V.

Mol Cell Biol. 1999 Mar;19(3):1950-60.

27.

Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway.

Matroule JY, Bonizzi G, Morlière P, Paillous N, Santus R, Bours V, Piette J.

J Biol Chem. 1999 Jan 29;274(5):2988-3000.

28.

Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells.

Bonizzi G, Piette J, Merville MP, Bours V.

J Immunol. 1997 Dec 1;159(11):5264-72.

PMID:
9548465
29.

Multiple redox regulation in NF-kappaB transcription factor activation.

Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville MP, Legrand-Poels S, Bours V.

Biol Chem. 1997 Nov;378(11):1237-45. Review.

PMID:
9426183
30.

Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates.

Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP, Bours V.

Eur J Biochem. 1996 Dec 15;242(3):544-9.

31.

Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.

Dejardin E, Bonizzi G, Bellahcène A, Castronovo V, Merville MP, Bours V.

Oncogene. 1995 Nov 2;11(9):1835-41.

PMID:
7478612

Supplemental Content

Loading ...
Support Center